Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality among
patients with end-stage renal disease (ESRD). Clustering of traditional atherosclerotic and …

Cardiac risk assessment before kidney transplantation has become widely accepted.
However, the optimal patient selection and screening tool for cardiac assessment remain …

Abstracts Background An AHA/ACCF scientific statement proposed 8 risk factors to assess
the need for noninvasive coronary artery disease (CAD) surveillance in asymptomatic …

Abstract Purpose of Review Patients with end-stage renal disease (ESRD) have an
increased risk of cardiovascular morbidity and mortality. Cardiac risk assessment, though …

Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

Background Secondary hyperparathyroidism is a common complication of end-stage renal
disease (ESRD), which may be associated with cardiovascular diseases. Thus, this study …

Background The significance of post-stress decrease in left ventricular ejection fraction
(LVEF) with regadenoson stress gated SPECT (GSPECT) myocardial perfusion imaging …

Purpose Noninvasive stress testing is commonly performed as part of pre-renal
transplantation (RT) evaluation. We evaluated the prognostic value of myocardial perfusion …

Regadenoson is a selective A 2A adenosine receptor agonist that has been approved as a
vasodilator stress agent with single-photon emission-computed tomography (SPECT) …

The ability to accurately predict future cardiovascular events has been the holy grail of
cardiovascular medicine. Thanks to a large body of supportive evidence, radionuclide …